All times in this program are Central European Time (UTC+1)
Timing | Title suggestions | Speaker suggestions |
---|---|---|
9:15-9:30 AM | Welcome Introduction | Florian Scotté, Villejuif |
9:30-10:00 AM | OPENING CEREMONY Challenges in cancer pathways | Aapro Matti , Genolier, Switzerland |
10:00-11:00 AM | PLENARY SESSION PREVENTION AND EARLY DETECTION, HOW TO IMPROVE Interception Program – dealing with high risk of cancer Multiple cancer early detection tests The example of poor prognosis cancer – a European effort Q/A | Suzette Delaloge, Villejuif Jean-Baptiste Meric, Bligny & Matthias Löhr , Heidelberg, Sweden |
11:00-11:30 AM | PLENARY SESSION THE CARE PATHWAY FOR BREAST CANCER | |
11:30-12:30 PM | PLENARY SESSION CARDIO-ONCOLOGY, HAPPY NEW YEAR VTE guidelines update implementation Arterial thrombo-embolism from comorbidities to adverse event Management of cardiologic long term events | Didier Mayeur, Dijon Ismail Elalamy, Paris Isabelle Mahé, Paris |
12:30-1:30 PM | Break / Symposium | |
1:30-2:30 PM | PLENARY SESSION NEUROLOGY New treatments in neuro-oncology (with safety approach) Specific management of patients with CNS tumor Anticancer drugs related neurotoxicity: from guidelines to daily practice | Emilie Le Rhun , Zurich, Switzerland Frederic Dhermain, Villejuif Antoine Lemaire , Valenciennes |
2:30-3:30 PM | PLENARY SESSION LUNG New treatments in lung cancer (with safety approach) Breathlessness Anticancer drugs related pulmonary toxicity: diffuse interstitial lung disease | David Hui, Houston, US |
3:30-4:15 PM | PLENARY SESSION LESSONS LEARNED FROM TREATING PATIENTS WITH CANCER DURING THE PANDEMIC AND CONTRIBUTIONS FOR THE FUTURE. Early palliative care: lessons since 2010 and post pandemic Supportive care in UK: post pandemic evolution Q/A | Camilla Zimmermann, Toronto, Canada Ashique Ahamed, Manchester, UK |
4:15-5:30 PM | YOUNG PHYSICIAN AWARD JEAN KLASTERSKY Presentation of the top clinical cases |
Timing | Title suggestions | Speaker suggestions |
---|---|---|
9:00-9:50 AM | EARLY SUPPORTIVE CARE – JUST A WORD? From early palliative to early supportive care, what is changing? Early assessment the way to move forward | Paolo Bossi, Brescia, Italy |
9:50-10:00 AM | MASCC 2024, A TASTE OF FRANCE | Mario Di Palma, Neuilly |
10:00-11:00 AM | PLENARY SESSION THE EARLY DRUGS CORNER Is there a model to better manage early drug safety : the fast track program New drugs in development Early drug trials, the last dance or a challenge to better communicate? New drugs MASCC study group | Christophe Massard, Rennes Stéphane Champiat, Villejuif Maria Die Trill, Madrid, Spain Christina Ruhlmann, Odense, Denmark |
11:00-12:00 AM | SYMPOSIUM | |
12:00-01:00 PM | PLENARY SESSION DIGITAL HEALTH Artificial Intelligence: no more physician needed? Remote monitoring and more Digital health in daily practice (nurse practitioner) | Matti Aapro, Genolier, Switzerland Andréas Charalambous, Turku, Finland Anna Letsch , Germany |
1:00-2:00 PM | Break | |
2:00-3:00 PM | PLENARY SESSION GI DISORDERS New treatments in GI oncology (with safety approach) CINV: new guidelines Diarrhea/constipation management | Richard Gralla, New York, US & Jeffrey Crawford , Durham, CA, US Jørn Herrstedt , København N., Denmark |
3:00-4:00 PM | PLENARY SESSION SURVIVORSHIP Back to work – when and why? The European white paper Back to work – why and how? The patient perspective | Maryam Lutsberg, New Haven, US Anne Sophie Tuszynski, Cancer@work |
4:00-5:00 PM | PLENARY SESSION SPECIFIC IMMUNE RELATED TOXICITIES Smoke gets in your eyes: ophtalmological toxicity A position paper on dermatological toxicity Managing endocrine disorders | |
5:00-5:30 PM | YOUNG PHYSICIAN AWARD JEAN KLASTERSKY Award ceremony: “And the winner is…” | |
5:30 PM | Closing ceremony: What are we waiting for in 2024 ? | Florian Scotté, Villejuif |
NOS
PARTENAIRES
OUR
PARTNERS